BERKELEY HEIGHTS, N.J., Nov. 4, 2010 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP), a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases, will announce third quarter 2010 financial results on Thursday November 11, 2010. The Company will host a conference call and live webcast at 4:30 pm Eastern time on the same day.
